Back
Also listed as
MKGAF
OTC
Day Range
$24.37
$24.53
52-Week Range
$23.76
$31.00
Volume
16,722
50D / 200D Avg
$28.74
/
$27.03
Prev Close
$23.92
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 21.2 | 0.2 |
| P/B | 1.9 | 3.0 |
| ROE % | 8.6 | 3.6 |
| Net Margin % | 12.4 | 3.8 |
| Rev Growth 5Y % | 0.7 | 10.0 |
| D/E | 0.4 | 0.2 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$2.20
$2.16 – $2.25
|
25.33B | 1 |
| FY2029 |
$2.08
$2.05 – $2.13
|
24.21B | 1 |
| FY2028 |
$1.89
$1.85 – $1.93
|
22.98B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-05 | $0.39 | $0.28 | -28.3% |
| 2025-11-13 | $0.54 | $0.81 | +50.0% |
| 2025-08-07 | $0.51 | $0.57 | +11.8% |
| 2025-05-15 | $0.50 | $0.59 | +18.0% |
| 2025-03-06 | $0.47 | $0.54 | +14.9% |
| 2024-11-14 | $0.49 | $0.68 | +38.8% |
| 2024-08-01 | $0.44 | $0.47 | +6.8% |
| 2024-05-15 | $0.43 | $0.45 | +4.7% |
Dividend History
7 yr streakYield
0.02%
Payout Ratio
0.40%
Growth (3Y)
7.21%
Growth (5Y)
11.42%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Apr 29, 2025 | May 07, 2025 | $0.50 | 1.81% |
| Apr 29, 2024 | May 09, 2024 | $0.47 | 1.47% |
| May 02, 2023 | May 11, 2023 | $0.49 | 1.34% |
| Apr 25, 2022 | May 04, 2022 | $0.41 | 1.06% |
| Apr 26, 2021 | May 05, 2021 | $0.34 | 0.96% |
| Jun 01, 2020 | Jun 10, 2020 | $0.29 | 1.21% |
| Apr 29, 2019 | May 09, 2019 | $0.28 | 1.32% |
| May 01, 2018 | May 10, 2018 | $0.30 | 1.58% |
| May 01, 2017 | May 19, 2017 | $0.44 | 1.10% |
| Apr 27, 2016 | May 17, 2016 | $0.40 | 1.28% |
| Apr 15, 2015 | May 05, 2015 | $0.36 | 0.94% |
| May 07, 2014 | May 27, 2014 | $0.87 | 1.59% |
| Apr 24, 2013 | May 14, 2013 | $0.75 | 1.46% |
| Apr 18, 2012 | May 08, 2012 | $0.66 | 1.84% |
| Apr 06, 2011 | Apr 26, 2011 | $0.60 | 1.89% |
| Apr 07, 2010 | Apr 27, 2010 | $0.45 | 1.70% |
| Apr 01, 2009 | Apr 21, 2009 | $0.66 | 2.19% |
| Mar 26, 2008 | Apr 10, 2008 | $1.66 | 3.90% |
Key Takeaways
Revenue grew 0.73% annually over 5 years — modest growth
Debt/Equity of 0.42 — conservative balance sheet
Generating 2.26B in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 4.92%
Cash machine — converts 90.03% of earnings into free cash flow
Capital efficient — spends only 7.51% of revenue on capex
Growth
Revenue Growth (5Y)
0.73%
Revenue (1Y)-4.19%
Earnings (1Y)-9.79%
FCF Growth (3Y)13.17%
Quality
Return on Equity
8.57%
ROIC7.22%
Net Margin12.36%
Op. Margin19.26%
Safety
Debt / Equity
0.42
Current Ratio1.46
Interest Coverage15.52
Valuation
P/E Ratio
21.20
Forward P/E15.57
P/B Ratio1.86
EV/EBITDA15.96
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -4.19% | Revenue Growth (3Y) | -1.74% |
| Earnings Growth (1Y) | -9.79% | Earnings Growth (3Y) | -5.82% |
| Revenue Growth (5Y) | 0.73% | Earnings Growth (5Y) | -4.84% |
| Profitability | |||
| Revenue (TTM) | 20.27B | Net Income (TTM) | 2.51B |
| ROE | 8.57% | ROA | 4.81% |
| Gross Margin | 56.35% | Operating Margin | 19.26% |
| Net Margin | 12.36% | Free Cash Flow (TTM) | 2.26B |
| ROIC | 7.22% | FCF Growth (3Y) | 13.17% |
| Safety | |||
| Debt / Equity | 0.42 | Current Ratio | 1.46 |
| Interest Coverage | 15.52 | ||
| Dividends | |||
| Dividend Yield | 0.02% | Payout Ratio | 0.40% |
| Dividend Growth (3Y) | 7.21% | Dividend Growth (5Y) | 11.42% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 21.20 | Forward P/E | 15.57 |
| P/B Ratio | 1.86 | P/S Ratio | 2.62 |
| PEG Ratio | -2.05 | Forward PEG | N/A |
| EV/EBITDA | 15.96 | Fwd EV/EBITDA | 10.60 |
| Forward P/S | 2.56 | Fwd Earnings Yield | 6.42% |
| FCF Yield | 4.25% | ||
| Market Cap | 53.11B | Enterprise Value | 62.33B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 20.27B | 21.16B | 20.99B | 22.23B | 19.69B |
| Net Income | 2.51B | 2.78B | 2.82B | 3.33B | 3.06B |
| EPS (Diluted) | 1.15 | 1.28 | 1.30 | 1.53 | 1.41 |
| Gross Profit | 11.42B | 12.49B | 12.39B | 13.71B | 12.34B |
| Operating Income | 3.90B | 3.65B | 3.61B | 4.47B | 4.18B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 52.08B | 51.57B | 48.50B | 48.53B | 45.36B |
| Total Liabilities | 23.43B | 21.58B | 21.74B | 22.52B | 23.95B |
| Shareholders' Equity | 28.58B | 29.91B | 26.68B | 25.93B | 21.34B |
| Total Debt | 11.96B | 10.27B | 9.86B | 10.40B | 10.77B |
| Cash & Equivalents | 2.74B | 2.15B | 1.98B | 1.40B | 1.51B |
| Current Assets | 13.22B | 13.45B | 12.39B | 12.20B | 10.98B |
| Current Liabilities | 9.04B | 11.29B | 8.70B | 9.51B | 10.43B |